Announcement under Regulation 30 (LODR)-Investor Presentation

We wish to give the following additional information on the Q1 FY23 financial results published on 12th August, '22. Refer Our earlier announcement no: AHCL/ SE/ 19 /2022-23 dated 12/08/2022

about 1 month ago



Sentiments detected

Positive 6
  • We are determined to hit our growth targets for the year by focusing more on the new formats and new categories while growing in new markets

  • Develop to improve our share in weak markets with core products in the balm category.

  • Continue to grow Exports, Modern Trade, and E-Com channels which have shown growth in Q1.

  • This category grew by 33% in Q1 and our Body roll-on has a long run way of growth as it is only available in 27% of our chemist outlets that any of the Amrutanjan product is available in.

  • We are eager to catch up with demand in the 2nd Summer that arrives in September and also in Q4FY23.

  • Comfy business continued to grow with an increase of 51% this Q1 versus the same period last year.

Negative 6
  • The macro picture: We have experienced a slowdown in the headache pain balm business during this period when compared to last year.

  • The bottom line of Q1FY23 was hit owing to higher advertising spends, an increase in RM / PM costs, freight charges, and post-pandemic sales expenses like travel and annual conferences which were revived after 2 years.

  • We have lost revenue of Rs.13.53 crores in Q1 FY23 which is a drop over Q1FY22 by 25.66% but higher than Q1FY21 revenue by 18.91%.

  • Electro+ plus revenue has declined in Q1 because of supply issues.

  • However, the new line from Taiwan did not arrive in time (due to Covid related interruptions) to complete the installation in Q3.

  • This has caused supply issues in Q4 last year and that has further rolled over into Q1 this year.

Mentioned Phrases & Organizations

Important keywords detected (20+)

new (6)
business (5)
last (5)
revenue (5)
amrutanjan (4)
growth (4)
category (4)
stock (3)
results (3)
continue (3)
grow (3)
markets (3)
line (3)
expenses (3)
ahcl (2)
mumbai (2)
investor (2)
presentation (2)
ended (2)
additional (2)

Organizations identified (3+)

Para A (1)
Modern Trade (1)

Tables extracted (2)

ParticularsQuarter Ended
Revenue from operations7,095.427,821.154,661.854,459.593,576.843,202.363,429.94
Other income301.25273.89204.56155.47132.01130.18113.59
Total income (I + II)7,396.678,095.044,866.414,615.063,708.853,332.543,543.53
(a) Cost of materials consumed2,673.202,663.46694.791,684.041,743.371,342.521,590.01
(b) Purchases of stock- in-trade1,339.601,081.01467.53829.62485.22611.63278.31
(c) Changes in inventories of finished goods and stock-in- trade- 513.93- 364.17970.79-72.07- 430.16- 414.08- 327.24
(d) Employee benefits expense1,210.981,225.06914.47910.82803.73800.03783.30
(e) Advertisement and selling expenditure989.19932.14355.60558.27612.65328.89249.61
(f) Finance cost2.448.484.485.191.7914.195.52
(g) Depreciation and amortisation expense106.7092.0494.8184.9571.8568.9963.02
(h) Other expenses1,063.44828.40497.82704.80624.85744.43598.48
Total expenses (IV)6,871.626,466.424,000.294,705.623,913.303,496.603,241.01
Profit before tax (III - IV)525.051,628.62866.12-90.56- 204.45- 164.06302.52
Tax expenses158.65422.88223.40-20.08-64.36-13.0191.95
Profit after tax from continuing operations (V - VI)366.401,205.74642.72-70.48- 140.09- 151.05210.57
Segment Revenue30/06/2230/06/2130/06/2030/06/1930/06/1830/06/1730/06/16
Segment Profit /(loss)
OTC442.231,338.35863.73- 143.536.27- 165.35355.19
F&B- 143.4685.63-75.228.58- 295.43-90.91- 114.38
Interest Cost-2.44-8.48-4.48-5.19-1.79-14.19-5.52
Other unallocable income net of expenses242.18247.90119.5183.40119.62100.7499.71
525.051,628.62866.12-90.56- 204.45- 164.06302.52

Features are experimental.